People News

Porter Novelli announced the appointment of Barbara DeBuono to chief medical officer, global director of public health and social marketing. She will report to Julie Winskie, president, Americas, and chief client officer. DuBuono, an adjunct professor at The George Washington University School of Public Health and Health Services, was formerly executive director, public health and government at Pfizer.

Synergy Pharmaceuticals, a biopharma focused on gastrointestinal disorders and diseases, appointed Alan Joslyn to its board of directors, as chairman of the corporate governance/nominating committee. Joslyn is currently CEO at Edusa Pharmaceuticals. Prior to Edusa, Joslyn served as president and CEO at Mt. Cook Pharma, SVP, research and development at Penwest Pharmaceuticals, and has held leadership roles in product development at Johnson & Johnson.
You must be a registered member of MMM to post a comment.

Next Article in Channel


Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.